Global Post-Traumatic Stress Disorder (PTSD) Market Research Report 2022

Global Post-Traumatic Stress Disorder (PTSD) Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Cognitive Therapy
1.2.3 Exposure Therapy
1.2.4 Eye Movement Desensitization And Reprocessing (EMDR)
1.2.5 Antidepressants
1.2.6 Anti-Anxiety Medications
1.2.7 Prazosin
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder (PTSD) Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Perspective (2017-2028)
2.2 Post-Traumatic Stress Disorder (PTSD) Growth Trends by Region
2.2.1 Post-Traumatic Stress Disorder (PTSD) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Region (2017-2022)
2.2.3 Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2023-2028)
2.3 Post-Traumatic Stress Disorder (PTSD) Market Dynamics
2.3.1 Post-Traumatic Stress Disorder (PTSD) Industry Trends
2.3.2 Post-Traumatic Stress Disorder (PTSD) Market Drivers
2.3.3 Post-Traumatic Stress Disorder (PTSD) Market Challenges
2.3.4 Post-Traumatic Stress Disorder (PTSD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue (2017-2022)
3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Players (2017-2022)
3.2 Global Post-Traumatic Stress Disorder (PTSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder (PTSD) Revenue
3.4 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder (PTSD) Revenue in 2021
3.5 Post-Traumatic Stress Disorder (PTSD) Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Type (2017-2022)
4.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2023-2028)
5 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Application (2017-2022)
5.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)
6.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)
6.3 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)
7.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)
7.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)
8.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)
8.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)
9.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)
9.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)
10.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)
10.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline (UK)
11.1.1 GlaxoSmithKline (UK) Company Detail
11.1.2 GlaxoSmithKline (UK) Business Overview
11.1.3 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Introduction
11.1.4 GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.1.5 GlaxoSmithKline (UK) Recent Development
11.2 Pfizer (US)
11.2.1 Pfizer (US) Company Detail
11.2.2 Pfizer (US) Business Overview
11.2.3 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.2.4 Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.2.5 Pfizer (US) Recent Development
11.3 Eli Lilly and Company (US)
11.3.1 Eli Lilly and Company (US) Company Detail
11.3.2 Eli Lilly and Company (US) Business Overview
11.3.3 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.3.4 Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.3.5 Eli Lilly and Company (US) Recent Development
11.4 Lundbeck A/S (Denmark)
11.4.1 Lundbeck A/S (Denmark) Company Detail
11.4.2 Lundbeck A/S (Denmark) Business Overview
11.4.3 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Introduction
11.4.4 Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.4.5 Lundbeck A/S (Denmark) Recent Development
11.5 Azevan Pharmaceuticals (US)
11.5.1 Azevan Pharmaceuticals (US) Company Detail
11.5.2 Azevan Pharmaceuticals (US) Business Overview
11.5.3 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.5.4 Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.5.5 Azevan Pharmaceuticals (US) Recent Development
11.6 Marinus Pharmaceuticals, Inc. (US)
11.6.1 Marinus Pharmaceuticals, Inc. (US) Company Detail
11.6.2 Marinus Pharmaceuticals, Inc. (US) Business Overview
11.6.3 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.6.4 Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.6.5 Marinus Pharmaceuticals, Inc. (US) Recent Development
11.7 Tonix Pharmaceuticals Holding Corp. (US)
11.7.1 Tonix Pharmaceuticals Holding Corp. (US) Company Detail
11.7.2 Tonix Pharmaceuticals Holding Corp. (US) Business Overview
11.7.3 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.7.4 Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.7.5 Tonix Pharmaceuticals Holding Corp. (US) Recent Development
11.8 Bionomics (Australia)
11.8.1 Bionomics (Australia) Company Detail
11.8.2 Bionomics (Australia) Business Overview
11.8.3 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Introduction
11.8.4 Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.8.5 Bionomics (Australia) Recent Development
11.9 Greenstone LLC (US)
11.9.1 Greenstone LLC (US) Company Detail
11.9.2 Greenstone LLC (US) Business Overview
11.9.3 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.9.4 Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.9.5 Greenstone LLC (US) Recent Development
11.10 Mylan NV (US)
11.10.1 Mylan NV (US) Company Detail
11.10.2 Mylan NV (US) Business Overview
11.10.3 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.10.4 Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.10.5 Mylan NV (US) Recent Development
11.11 Otsuka Pharmaceutical (Japan)
11.11.1 Otsuka Pharmaceutical (Japan) Company Detail
11.11.2 Otsuka Pharmaceutical (Japan) Business Overview
11.11.3 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Introduction
11.11.4 Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.11.5 Otsuka Pharmaceutical (Japan) Recent Development
11.12 Prometheon Pharma (USA)
11.12.1 Prometheon Pharma (USA) Company Detail
11.12.2 Prometheon Pharma (USA) Business Overview
11.12.3 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.12.4 Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.12.5 Prometheon Pharma (USA) Recent Development
11.13 Ligand Pharma (USA)
11.13.1 Ligand Pharma (USA) Company Detail
11.13.2 Ligand Pharma (USA) Business Overview
11.13.3 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.13.4 Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.13.5 Ligand Pharma (USA) Recent Development
11.14 Valenta Pharm (Russia)
11.14.1 Valenta Pharm (Russia) Company Detail
11.14.2 Valenta Pharm (Russia) Business Overview
11.14.3 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Introduction
11.14.4 Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.14.5 Valenta Pharm (Russia) Recent Development
11.15 Lycera Corp (US)
11.15.1 Lycera Corp (US) Company Detail
11.15.2 Lycera Corp (US) Business Overview
11.15.3 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.15.4 Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.15.5 Lycera Corp (US) Recent Development
11.16 Archimedes (UK)
11.16.1 Archimedes (UK) Company Detail
11.16.2 Archimedes (UK) Business Overview
11.16.3 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Introduction
11.16.4 Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.16.5 Archimedes (UK) Recent Development
11.17 GMP Endotherapeutics (USA)
11.17.1 GMP Endotherapeutics (USA) Company Detail
11.17.2 GMP Endotherapeutics (USA) Business Overview
11.17.3 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.17.4 GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.17.5 GMP Endotherapeutics (USA) Recent Development
11.18 Nuvo Pharmaceuticals (Canada)
11.18.1 Nuvo Pharmaceuticals (Canada) Company Detail
11.18.2 Nuvo Pharmaceuticals (Canada) Business Overview
11.18.3 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Introduction
11.18.4 Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.18.5 Nuvo Pharmaceuticals (Canada) Recent Development
11.19 Beijing Wansheng Pharmaceutical
11.19.1 Beijing Wansheng Pharmaceutical Company Detail
11.19.2 Beijing Wansheng Pharmaceutical Business Overview
11.19.3 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.19.4 Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.19.5 Beijing Wansheng Pharmaceutical Recent Development
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Company Detail
11.20.2 Zhejiang Huahai Pharmaceutical Business Overview
11.20.3 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.20.4 Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.20.5 Zhejiang Huahai Pharmaceutical Recent Development
11.21 Zhejiang Jianfeng Pharmaceutical
11.21.1 Zhejiang Jianfeng Pharmaceutical Company Detail
11.21.2 Zhejiang Jianfeng Pharmaceutical Business Overview
11.21.3 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.21.4 Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.21.5 Zhejiang Jianfeng Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Cognitive Therapy
Table 3. Key Players of Exposure Therapy
Table 4. Key Players of Eye Movement Desensitization And Reprocessing (EMDR)
Table 5. Key Players of Antidepressants
Table 6. Key Players of Anti-Anxiety Medications
Table 7. Key Players of Prazosin
Table 8. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2017-2022)
Table 12. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2023-2028)
Table 14. Post-Traumatic Stress Disorder (PTSD) Market Trends
Table 15. Post-Traumatic Stress Disorder (PTSD) Market Drivers
Table 16. Post-Traumatic Stress Disorder (PTSD) Market Challenges
Table 17. Post-Traumatic Stress Disorder (PTSD) Market Restraints
Table 18. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players (2017-2022)
Table 20. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2021)
Table 21. Ranking of Global Top Post-Traumatic Stress Disorder (PTSD) Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service
Table 25. Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2017-2022)
Table 29. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2023-2028)
Table 31. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Application (2017-2022)
Table 33. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Application (2023-2028)
Table 35. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2017-2022) & (US$ Million)
Table 40. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2023-2028) & (US$ Million)
Table 41. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)
Table 42. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)
Table 43. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)
Table 44. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)
Table 45. GlaxoSmithKline (UK) Company Detail
Table 46. GlaxoSmithKline (UK) Business Overview
Table 47. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product
Table 48. GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 49. GlaxoSmithKline (UK) Recent Development
Table 50. Pfizer (US) Company Detail
Table 51. Pfizer (US) Business Overview
Table 52. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 53. Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 54. Pfizer (US) Recent Development
Table 55. Eli Lilly and Company (US) Company Detail
Table 56. Eli Lilly and Company (US) Business Overview
Table 57. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 58. Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 59. Eli Lilly and Company (US) Recent Development
Table 60. Lundbeck A/S (Denmark) Company Detail
Table 61. Lundbeck A/S (Denmark) Business Overview
Table 62. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product
Table 63. Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 64. Lundbeck A/S (Denmark) Recent Development
Table 65. Azevan Pharmaceuticals (US) Company Detail
Table 66. Azevan Pharmaceuticals (US) Business Overview
Table 67. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 68. Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 69. Azevan Pharmaceuticals (US) Recent Development
Table 70. Marinus Pharmaceuticals, Inc. (US) Company Detail
Table 71. Marinus Pharmaceuticals, Inc. (US) Business Overview
Table 72. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 73. Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 74. Marinus Pharmaceuticals, Inc. (US) Recent Development
Table 75. Tonix Pharmaceuticals Holding Corp. (US) Company Detail
Table 76. Tonix Pharmaceuticals Holding Corp. (US) Business Overview
Table 77. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 78. Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 79. Tonix Pharmaceuticals Holding Corp. (US) Recent Development
Table 80. Bionomics (Australia) Company Detail
Table 81. Bionomics (Australia) Business Overview
Table 82. Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Product
Table 83. Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 84. Bionomics (Australia) Recent Development
Table 85. Greenstone LLC (US) Company Detail
Table 86. Greenstone LLC (US) Business Overview
Table 87. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 88. Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 89. Greenstone LLC (US) Recent Development
Table 90. Mylan NV (US) Company Detail
Table 91. Mylan NV (US) Business Overview
Table 92. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 93. Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 94. Mylan NV (US) Recent Development
Table 95. Otsuka Pharmaceutical (Japan) Company Detail
Table 96. Otsuka Pharmaceutical (Japan) Business Overview
Table 97. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD)Product
Table 98. Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 99. Otsuka Pharmaceutical (Japan) Recent Development
Table 100. Prometheon Pharma (USA) Company Detail
Table 101. Prometheon Pharma (USA) Business Overview
Table 102. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD)Product
Table 103. Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 104. Prometheon Pharma (USA) Recent Development
Table 105. Ligand Pharma (USA) Company Detail
Table 106. Ligand Pharma (USA) Business Overview
Table 107. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD)Product
Table 108. Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 109. Ligand Pharma (USA) Recent Development
Table 110. Valenta Pharm (Russia) Company Detail
Table 111. Valenta Pharm (Russia) Business Overview
Table 112. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD)Product
Table 113. Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 114. Valenta Pharm (Russia) Recent Development
Table 115. Lycera Corp (US) Company Detail
Table 116. Lycera Corp (US) Business Overview
Table 117. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD)Product
Table 118. Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 119. Lycera Corp (US) Recent Development
Table 120. Archimedes (UK) Company Detail
Table 121. Archimedes (UK) Business Overview
Table 122. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD)Product
Table 123. Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 124. Archimedes (UK) Recent Development
Table 125. GMP Endotherapeutics (USA) Company Detail
Table 126. GMP Endotherapeutics (USA) Business Overview
Table 127. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD)Product
Table 128. GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 129. GMP Endotherapeutics (USA) Recent Development
Table 130. Nuvo Pharmaceuticals (Canada) Company Detail
Table 131. Nuvo Pharmaceuticals (Canada) Business Overview
Table 132. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD)Product
Table 133. Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 134. Nuvo Pharmaceuticals (Canada) Recent Development
Table 135. Beijing Wansheng Pharmaceutical Company Detail
Table 136. Beijing Wansheng Pharmaceutical Business Overview
Table 137. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD)Product
Table 138. Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 139. Beijing Wansheng Pharmaceutical Recent Development
Table 140. Zhejiang Huahai Pharmaceutical Company Detail
Table 141. Zhejiang Huahai Pharmaceutical Business Overview
Table 142. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD)Product
Table 143. Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 144. Zhejiang Huahai Pharmaceutical Recent Development
Table 145. Zhejiang Jianfeng Pharmaceutical Company Detail
Table 146. Zhejiang Jianfeng Pharmaceutical Business Overview
Table 147. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD)Product
Table 148. Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
Table 149. Zhejiang Jianfeng Pharmaceutical Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Type: 2021 VS 2028
Figure 2. Cognitive Therapy Features
Figure 3. Exposure Therapy Features
Figure 4. Eye Movement Desensitization And Reprocessing (EMDR) Features
Figure 5. Antidepressants Features
Figure 6. Anti-Anxiety Medications Features
Figure 7. Prazosin Features
Figure 8. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Application in 2021 & 2028
Figure 9. Children Case Studies
Figure 10. Adult Case Studies
Figure 11. Post-Traumatic Stress Disorder (PTSD) Report Years Considered
Figure 12. Global Post-Traumatic Stress Disorder (PTSD) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Post-Traumatic Stress Disorder (PTSD) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region: 2021 VS 2028
Figure 15. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players in 2021
Figure 16. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue in 2021
Figure 18. North America Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2017-2028)
Figure 20. United States Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2017-2028)
Figure 24. Germany Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2017-2028)
Figure 32. China Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2017-2028)
Figure 40. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2017-2028)
Figure 44. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. GlaxoSmithKline (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 47. Pfizer (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 48. Eli Lilly and Company (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 49. Lundbeck A/S (Denmark) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 50. Azevan Pharmaceuticals (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 51. Marinus Pharmaceuticals, Inc. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 52. Tonix Pharmaceuticals Holding Corp. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 53. Bionomics (Australia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 54. Greenstone LLC (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 55. Mylan NV (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 56. Otsuka Pharmaceutical (Japan) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 57. Prometheon Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 58. Ligand Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
Figure 59. Valenta Pharm (Russia) Revenue Growth Rate in Post-Traumat

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs